EX-23.2 2 y74822a3exv23w2.htm EX-23.2: CONSENT OF KPMG LLP EX-23.2
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Pfizer Inc.:
We consent to the use of our reports with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.
         
 
  /s/ KPMG LLP    
New York, New York
June 9, 2009